Michelle A. Eugeni

CLINICAL, GENETIC AND RADIOGRAPHIC ANALYSIS OF 108 PATIENTS WITH VON HIPPEL-LINDAU DISEASE (vHL) MANIFESTED BY PANCREATIC NEUROENDOCRINE TUMORS (PNETs)

P. Choyke, W. Linehan, H. Alexander, 2019 .

Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).

Peter L Choyke, W Marston Linehan, S. Libutti, 2007, Surgery.

Preliminary results of a phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine

S. Libutti, G. Paciotti, L. Myer, 2007 .

First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile

L. Rubinstein, J. Doroshow, A. Chen, 2018, Investigational New Drugs.

Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer

L. Rubinstein, J. Doroshow, L. Doyle, 2015, Investigational New Drugs.

Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies.

S. Libutti, B. Wood, R. Poon, 2012, Journal of vascular and interventional radiology : JVIR.

A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer.

S. Steinberg, P. Choyke, M. Raffeld, 2015, Clinical colorectal cancer.

Abstract 2416: Weekly EZN-2208 (pegylated SN-38) in combination with bevacizumab in patients with refractory solid tumors.

J. Doroshow, A. Chen, B. Turkbey, 2013 .